Search research articles
Contact Us
Filters
Showing results (431-440 of 1,058) with videos related to
Page
of 106
Sort By:
Journal of Alternative and Complementary Medicine (New York, N.Y.)
|
November 4, 2000
Use of herbal therapies by adults seen in an ambulatory care research setting: an exploratory survey
E M Johnson, J C Wootton, R Kimzey, et al.
British Journal of Haematology
|
August 19, 2014
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
Farrukh T Awan, Peter Hillmen, Andrzej Hellmann, et al.
The Journal of Organic Chemistry
|
October 11, 2023
Investigation into a Conformationally Locked <i>(Z)</i>-Azidoxime
Alexander H Cleveland, Jack V Davis, Gregory H Imler, et al.
Cancer Medicine
|
August 28, 2023
Real-world genomic testing and treatment patterns of newly diagnosed adult acute myeloid leukemia patients within a comprehensive health system
John C Byrd, Jennifer L Gatz, Cynthia Lim Louis, et al.
Cancer
|
July 13, 2006
Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia
Stefan Faderl, Kanti Rai, John Gribben, et al.
Cancer Research
|
February 1, 1991
Relationship of pancreatic cancer apomucin to mammary and intestinal apomucins
J C Byrd, J J Ho, D T Lamport, et al.
Blood
|
September 27, 2014
IPI-145 antagonizes intrinsic and extrinsic survival signals in chronic lymphocytic leukemia cells
Shuai Dong, Daphne Guinn, Jason A Dubovsky, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 19, 2013
Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties
Sarwish Rafiq, Jonathan P Butchar, Carolyn Cheney, et al.
The Journal of Clinical Investigation
|
June 14, 2008
Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug
Alan G Ramsay, Amy J Johnson, Abigail M Lee, et al.
Cancer Genetics
|
April 16, 2011
Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate
Natarajan Muthusamy, Heather Breidenbach, Leslie Andritsos, et al.
Page
of 106
Search research articles
Search
Showing results (431-440 of 1,058) with videos related to
Sort By:
Page
of 106
Journal of Alternative and Complementary Medicine (New York, N.Y.)
|
November 4, 2000
Use of herbal therapies by adults seen in an ambulatory care research setting: an exploratory survey
E M Johnson, J C Wootton, R Kimzey, et al.
British Journal of Haematology
|
August 19, 2014
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
Farrukh T Awan, Peter Hillmen, Andrzej Hellmann, et al.
The Journal of Organic Chemistry
|
October 11, 2023
Investigation into a Conformationally Locked <i>(Z)</i>-Azidoxime
Alexander H Cleveland, Jack V Davis, Gregory H Imler, et al.
Cancer Medicine
|
August 28, 2023
Real-world genomic testing and treatment patterns of newly diagnosed adult acute myeloid leukemia patients within a comprehensive health system
John C Byrd, Jennifer L Gatz, Cynthia Lim Louis, et al.
Cancer
|
July 13, 2006
Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia
Stefan Faderl, Kanti Rai, John Gribben, et al.
Cancer Research
|
February 1, 1991
Relationship of pancreatic cancer apomucin to mammary and intestinal apomucins
J C Byrd, J J Ho, D T Lamport, et al.
Blood
|
September 27, 2014
IPI-145 antagonizes intrinsic and extrinsic survival signals in chronic lymphocytic leukemia cells
Shuai Dong, Daphne Guinn, Jason A Dubovsky, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 19, 2013
Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties
Sarwish Rafiq, Jonathan P Butchar, Carolyn Cheney, et al.
The Journal of Clinical Investigation
|
June 14, 2008
Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug
Alan G Ramsay, Amy J Johnson, Abigail M Lee, et al.
Cancer Genetics
|
April 16, 2011
Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate
Natarajan Muthusamy, Heather Breidenbach, Leslie Andritsos, et al.
Page
of 106